Argentum Pharmaceuticals LLC v. Janssen Oncology, Inc. > Summary
Court Case Number IPR2016-01317
Filing Date Jun 29, 2016
Institution Decision Date Sep 19, 2016
Decision Date Jan 17, 2018
Court Patent Trial and Appeal Board
Status FWD Entered
Appeal2019-1323
Administrative JudgesKristina M. Kalan, Lora M. Green, Rama G. Elluru
Judge Writing the Final DecisionKristina M. Kalan
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
Claims Invalidated: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
Petitioner
Patent Owner
Petitioner Attorneys
4Argentum Pharmaceuticals
Attorney Name: Shannon M. Lentz
Crowell & Moring
Patent Owner Attorneys
4Jackson & Johnson
Attorney Name: Barbara L. Mullin
Akin Gump Strauss Hauer & Feld
Jackson & Johnson
Attorney Name: Dianne B. Elderkin
Akin Gump Strauss Hauer & Feld
Attorney Name: Joseph Frank Shirtz
Johnson & Johnson
Related Patents
Doc No | Title | Issue date |
---|---|---|
08822438 | Methods and compositions for treating cancer | Sep 2, 2014 |